Restrictions in process design: A case study on workflows in healthcare

Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

Volumn 4928 LNCS, Issue , 2008, Pages 323-334

  Becker, Jörg ^a   Janiesch, Christian ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Design restrictions; Healthcare; Infection control; Process design; Process management; Workflow management

Indexed keywords

HEALTH CARE; INFORMATION MANAGEMENT;

BUSINESS PROCESS REENGINEERING; PROCESS MANAGEMENT; WORKFLOW MANAGEMENT;

PROCESS DESIGN;

EID: 40549131573     PISSN: 03029743     EISSN: 16113349     Source Type: Book Series    
DOI: 10.1007/978-3-540-78238-4_34     Document Type: Conference Paper

References (28)

1. Becker, J., Kugeler, M., Rosemann, M. (eds.): Process Management: A Guide for the Design of Business Processes, 2nd edn. Springer, Berlin (to appear, 2007)
2. Becker, J., zur Mühlen, M.: Towards a Classification Framework:, for Application Granularity in Workflow Management Systems. In: Jarke, M., Oberweis, A. (eds.) CAiSE 1999. LNCS, vol. 1626, pp. 411-416. Springer, Heidelberg (1999)
3. Borst, F., et al.: Happy Birthday DIOGENE: A Hospital Information System. Born 20 Years Ago. International Journal of Medical Informatics 54, 157-167 (1999)
4. Burke, J.P.: Infection Control: A Problem for Patient. Safety. New England Journal of Medicine 348, 651-656 (2003)
5. Centers for Disease Control and Prevention (CDC): National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992 through June 2004, Issued October 2004. American Journal of Infection Control 32, 470-485 (2004)
6. Dewire, D.T.: Application Service Providers. Information Systems Management. 17, 14-19 (2000)
7. DiMasi, J.A., Hansen, R.W., Grabowski, H.G.: The Price of Innovation: New Estimates of Drug Development Costs. Journal of Health Economics 22, 151-185 (2003)
8. Hammer, M., Champy, J.: Reengineering the Corporation: A Manifesto for Business Revolution, 1st edn. HarperBusiness, New York (1993)
9. Harmon, P.: Business Process Change: A Manager's Guide to Improving, Redesigning, and Automating Processes. Morgan Kaufmann, San Francisco, CA (2003)
10. Institute of Medicine: Crossing the quality chasm: A New Health System for the 21st Century. National Academies Press, Washington, DC (2001)
11. Kohn, L.T., Corrigan, J.M., Donaldson, M.S. (eds.): To Err is Human: Building a Safer Health System. National. Academy Press, Washington, DC (2000)
12. Lenz, R., Reichert, M.: IT Support for Healthcare Processes. In: van der Aalst, W.M.P., Benatallah, B., Casati, F., Curbera, F. (eds.) BPM 2005. LNCS, vol. 3649, pp. 354-363. Springer, Heidelberg (2005)
13. Magruder, C., Burke, M., Hann, N.E., Ludovic, J.A.: Using Information Technology to Improve the Public Health System. Journal of Public Health Management and Practice 11, 123-130 (2005)
14. Object. Management Group: Business Process Modeling Notation (BPMN) Specification 1.0 (2006), Available: http://www.omg.org/cgi-bin/apps/doc?dtc/06- 02-01.pdf
15. Panzarasa, S., Stefanelli, M.: Workflow Management. Systems for Guideline Implementation. Neurological Sciences 27, 245-249 (2006)
16. Porter, M.E.: Competitive Advantage: Creating and Sustaining Superior Performance. The Free Press, New York (1985)
17. Pryor, T.A., Hripcsak, G.: The Arden Syntax for Medical Logic Modules. International Journal of Clinical Monitoring and Computing 10, 215-224 (1993)
18. Siemens AG: Soarian® (2007), Available: http://www.soarian.com/
19. Tao, L.: Shifting Paradigms with the Application Service Provider Model. IEEE Computer 34, 32-39 (2001)
20. The Joint Commission: 2007 National Patient Safety Goals (2007), Available: http://www.jointcommission.org/PatientSafety/NationalPatient. SafetyGoals/07_hap_cah_ npsgs.htm
21. The Medical Letter Inc.: Choice of Antibacterial Drugs. Treatment Guidelines from The Medical Letter 2, 13-26 (2004)
22. The Medical Letter Inc.: Treatment of Clostridium. Difficile-Associated Disease (CDAD). The Medical Letter on Drugs and Therapeutics 48, 89-90 (2006)
23. TIBCO Software GmbH: TIBCO® Staffware Process Suite (2005), Available: http://bpmleader.tibco.com/de/docs/staffware_processsui.te_datasheet. pdf
24. U.S. Food and Drug Administration: Public Health Service Act. (1944), Available: http://www.fda.gov/opacom/laws/phsvcact/phsvcact.htm
25. van der Aalst, W.M.P., ter Hofstede, A.H.M., Weske, M.: Business Process Management: A Survey. In: van der Aalst, W.M.P., ter Hofstede, A.H.M., Weske, M. (eds.) BPM 2003. LNCS, vol. 2678, pp. 1-12. Springer, Heidelberg (2003)
26. Weber, S.G., et. al.: Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococci: Position Statement From the Joint SHEA and APIC Task Force. Infection Control and Hospital. Epidemiology 28, 249-260 (2007)
27. Workflow Managment Coalition: Terminology & Glossary 3.0 (1999), Available: http://www.wfmc.org/standards/docs/TC-101.l_tenn_glossary_v3.pdf
28. zur Mühlen, M.: Workflow-based Process Controlling: Foundation, Design and Application of Workflow-driven Process Information Systems. Dissertation. Logos, Berlin. (2004)